1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Oryza Pharmaceuticals Shenzhen Limited has 1 pending office action. The matter is assigned to 1 distinct examiner, MILLER, MAKENNA RYLEIGH, who is also the listed busiest examiner with 1 pending matter.
The profile records 0 distinct art units. Counsel should therefore focus on the identified examiner and clarify the examination record before relying on art-unit-based prosecution assumptions.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MILLER, MAKENNA RYLEIGH | 1 | 100.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18904685 | TOFACITINIB CITRATE SUSTAINED-RELEASE TABLET AND PREPARATION METHOD THEREOF | MILLER, MAKENNA RYLEIGH | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18904685 | TOFACITINIB CITRATE SUSTAINED-RELEASE TABLET AND PREPARATION METHOD THEREOF | MILLER, MAKENNA RYLEIGH | — | §103§112 | Non-Final OA | — | Pending | Oct 02, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialOryza Pharmaceuticals Shenzhen Limited has 1 pending office actions as of October 2026, spread across 0 art units and 1 examiners.
Makenna Ryleigh Miller has the most, with 1 of Oryza Pharmaceuticals Shenzhen Limited's pending office actions.
